Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Millions.
The item "Interest-Income" stands at 279.00 Million Euros for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2023.
Sanofi SA's third quarter result of 114.00 Million EUR for the item "Interest Income" represents an increase of 46.15 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 114.00 Million EUR for the item "Interest Income" represents a decrease of -14.29 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 279.00 Million EUR for the item "Interest Income" represents a decrease of -6.38 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -43.41 percent compared to the value the year prior.
The 1 year change in percent is -43.41.
The 3 year change in percent is 190.62.
The 5 year change in percent is 469.39.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Interest Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Interest Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Income | 280,205,508,085.11 |